SK Biopharmaceuticals Co., Ltd. (KRX:326030)
109,200
0.00 (0.00%)
At close: Feb 13, 2026
-12.22% (1Y)
| Market Cap | 8.55T -0.5% |
| Revenue (ttm) | 675.41B +32.1% |
| Net Income | 320.47B +458.5% |
| EPS | 4,092.19 +458.8% |
| Shares Out | 78.31M |
| PE Ratio | 26.68 |
| Forward PE | 32.22 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 376,075 |
| Average Volume | 259,505 |
| Open | 112,500 |
| Previous Close | n/a |
| Day's Range | 108,800 - 112,700 |
| 52-Week Range | 86,900 - 144,100 |
| Beta | 0.79 |
| RSI | 35.92 |
| Earnings Date | Feb 4, 2026 |